The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
For last few years, researchers are increasingly employing machine learning methods in the domain of cancer prognosis. The main reason behind these efforts is to help oncologist to make accurate and less invasive decisions for the patient's treatment. Moreover, it would relieve many cancer patients from agonizingly complex surgical treatments and their colossal costs. In this paper, we have proposed...
Selection of an appropriate classifier for computer-aided diagnosis (CAD) applications has typically been an ad hoc process. It is difficult to know a priori which classifier will yield high accuracies for a specific application, especially when well-annotated data for classifier training is scarce. In this study, we utilize an inverse power-law model of statistical learning to predict classifier...
The prediction of outcome in newborns with hypoxic ischemic encephalopathy (HIE) is a problematic task. Here, the ability of a combination of clinical, heart rate and EEG measures to predict outcome at 2 years is investigated. One hour of EEG and ECG recordings were obtained from newborns 24 hours after birth. Each newborn was reassessed at 24 months to investigate their neurodevelopmental outcome...
The current gold standard for predicting disease survival and outcome for lymph node-negative, estrogen receptor-positive breast cancer (LN-, ER+ BC) patients is via the gene-expression based assay, Oncotype DX. In this paper, we present a novel computer-aided prognosis (CAP) scheme that employs quantitatively derived image information to predict patient outcome analogous to the Oncotype DX recurrence...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.